Clinical Trial Update: Systematic Review: Retigabine for Adjunctive Therapy in Partial Epilepsy

View source ↗

Summary

A systematic review evaluating retigabine as adjunctive therapy in partial epilepsy, summarizing available trial evidence on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Potiga (ezogabine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Epilepsy | Status: COMPLETED